India Sector Consolidation Regulatory Filings — June 26, 2026

26-06-2026

Cyber Media (India) Limited (CMIL) has received 'no adverse observations' from BSE and a 'No objection' letter from NSE for its proposed scheme of merger by absorption of its subsidiary Cyber Media Research & Services Limited (CMRSL) into CMIL. The observation letters, dated June 25, 2026, were received on June 26, 2026, and include several compliance conditions from SEBI, such as ensuring the scheme complies with LODR regulations, disclosing ongoing enforcement actions, and providing detailed financial and risk information to shareholders. The scheme remains subject to further regulatory approvals, including from the NCLT, and the NSE observation letter is valid for six months.

• · The observation letters were received from BSE and NSE on June 25, 2026, and the company intimated the stock exchanges on June 26, 2026.
• · The NSE observation letter includes 20 specific compliance conditions (a through r) that the companies must adhere to.
• · The NSE observation letter is valid for six months from June 25, 2026, within which the scheme must be submitted to NCLT.
• · The scheme was initially approved by the Board on January 24, 2026, and the application was filed with BSE and NSE on January 31, 2026.
• · The observation letters are available on the company's websites: https://cybermedia.co.in/ and https://www.cmrsl.net/.

26-06-2026

Tilaknagar Industries Limited (TI) has approved a further investment of ₹2 Crore in Round the Cocktails Private Limited (Bartisans) by subscribing to 1,569 Compulsory Convertible Preference Shares at ₹12,752 per CCPS. Post investment, TI's stake in Bartisans will increase to 41.45%. Bartisans, a ready-to-pour cocktail mixer company, reported flat turnover of ₹3.5 Cr in FY26 (same as FY24) and net worth of ₹1.0 Cr, indicating stagnant top-line performance despite TI's continued backing.

• · Bartisans was incorporated on 19-Aug-2021.
• · The investment is a cash consideration transaction.
• · Completion of the acquisition is expected on or before 31st August 2026.
• · The transaction is at arm's length and does not involve related parties.
• · Bartisans' net worth as of March 31, 2026 is only ₹1.0 Crore, indicating a thin equity base.
• · No governmental or regulatory approvals are required for the acquisition.

26-06-2026

Gujarat Fluorochemicals Limited (GFCL) has incorporated a wholly-owned subsidiary, GFCL Semiconductor and Advanced Materials Limited, on June 26, 2026, in India. The subsidiary will operate in specialty chemicals and semiconductor devices, including integrated circuits. The company subscribed to equity shares at a cost of ₹1 Lakh, representing 100% shareholding.

• · The subsidiary is incorporated in India.
• · The subsidiary's business includes designing, developing, manufacturing, and dealing in specialty chemicals, semiconductor devices, integrated circuits, electronic components, software, and related technologies.
• · No governmental or regulatory approvals were required for the incorporation.
• · The consideration is in cash.

26-06-2026

Powerica Ltd announced the incorporation of a wholly owned subsidiary, Windfusion Renewable Private Limited, on June 26, 2026, with the approval of the Ministry of Corporate Affairs. The subsidiary is focused on renewable energy projects including wind, solar, and hybrid power. Powerica subscribed to 100% of the subsidiary's paid-up share capital (250,000 equity shares at ₹10 each) for a total cash consideration of ₹2,500,000.

• · The subsidiary is incorporated in India under the Companies Act.
• · The subsidiary's main objects include setting up and developing wind, solar, wind-solar hybrid, and other renewable power projects.
• · No governmental or regulatory approvals were required for the incorporation beyond the Ministry of Corporate Affairs approval.
• · The consideration is in cash and the listed entity holds 100% control over the WOS.

26-06-2026

Sunteck Realty Limited has incorporated a wholly-owned subsidiary, Eminara Buildcon Private Limited (EBPL), on June 26, 2026, for real estate activities. The company subscribed to 10,000 equity shares of ₹10 each for a total cash consideration of ₹1,00,000, resulting in 100% ownership. This is a routine corporate structuring move with no related-party or regulatory approval implications.

• · The subsidiary is incorporated in India and classified under the real estate industry.
• · No governmental or regulatory approvals were required for the incorporation.
• · The transaction is not a related-party transaction, and no promoter/group entities have an interest in EBPL.

26-06-2026

Bharatam Ventures Limited (formerly Pet Plastics Ltd.) completed the acquisition of a 99.9987% equity stake in Penganga Sakhar Karkhana Private Limited for a cash consideration of ₹1,79,99,760 (₹1.79 Crore). The target company is engaged in sugar manufacturing and allied agro-processing, with turnover growing from ₹1,404 Lakh in FY24 to ₹8,352.89 Lakh in FY26. The acquisition is a strategic diversification into the sugar sector, but no financial details of the acquirer or funding sources were disclosed.

• · The acquisition was completed on June 26, 2026, following a disclosure on May 28, 2026.
• · The target company's turnover grew from ₹1,404 Lakh in FY24 to ₹8,352.89 Lakh in FY26, showing rapid growth.
• · The acquisition is not a related party transaction and was done on an arm's length basis.
• · No governmental or regulatory approvals are pending post-completion.

26-06-2026

Kisan Mouldings Limited (KML) has approved a two-stage Scheme of Arrangement to amalgamate first its wholly owned subsidiary KML Tradelinks Private Limited (KTPL) into itself, and then amalgamate KML into Apollo Pipes Limited (APL). The scheme, effective from April 1, 2026, will see KML shareholders receive 4.96 equity shares of APL for every 100 shares held. The combined entity aims to achieve operational synergies, economies of scale, and enhanced market competitiveness, though the transaction will result in the delisting of KML and the cancellation of its equity shares.

• · The appointed date for the scheme is April 1, 2026.
• · KML's promoter shareholding pre-arrangement was 70.56% (8,42,87,623 shares); post-arrangement, all KML shares are cancelled.
• · APL's promoter shareholding post-arrangement will be 49.20% (2,27,80,000 shares) compared to 51.72% pre-arrangement, while public shareholding will increase from 47.99% to 50.52%.
• · The share exchange ratio is 4.96 equity shares of APL (face value ₹10 each) for every 100 equity shares of KML (face value ₹10 each).
• · KTPL has zero turnover and negligible net worth (₹0.02 Cr), making its amalgamation a purely structural step.
• · The scheme is subject to approvals from shareholders, creditors, stock exchanges, SEBI, NCLT, and other regulatory authorities.

26-06-2026

Rashi Goenka, a promoter group member of GAMCO LIMITED, acquired 53,000 equity shares (0.10% of total capital) via open market transactions on June 24-25, 2026, increasing her holding from 2.70% to 2.80% of the paid-up equity share capital. The acquisition was disclosed under SEBI SAST Regulations.

• · Face value of each equity share is Rs. 2/-.
• · Acquisition was made through open market transactions over two days (24-06-2026 to 25-06-2026).
• · Total diluted share capital after acquisition is Rs. 10,80,63,000/- consisting of 5,40,31,500 equity shares.

26-06-2026

Clean Science and Technology Limited reported an inter-se transfer of 2,00,38,000 equity shares (representing 18.86% of the company's share capital) among promoters and promoter group members by way of gift, with no consideration involved. The transfers were executed from Ashok Ramnarayan Boob, Asha Ashok Boob, and Nilima Krishnakumar Boob to ARB Business Trust, AAB Business Trust, Asha Ashok Boob, and Alaknanda Business Trust. As this is a reorganisation of holdings within the promoter group with no change in ultimate control, the filing is procedural in nature and does not reflect a change in corporate ownership or financial performance.

• · Transfers were executed via off-market inter-se gift without any consideration.
• · The transfers are made under Regulation 10(1)(a)(ii) of the SEBI SAST Regulations.
• · The total transferred shares amount to 18.86% of the company's share capital.
• · Prior intimations were filed on 1st June 2026 (Reg 10(5)) and 10th/11th June 2026 (Reg 10(6)).
• · The disclosures were submitted on the SEBI Intermediary Portal (SI Portal) with application numbers 684, 701, 702, and 683 between 22–23 June 2026.

26-06-2026

Ipca Laboratories Limited has approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd., its subsidiary, to achieve operational synergies, secure supply of critical fermentation-based APIs and drug intermediates, and enable R&D for new fermentation-based products. The transaction involves a share-swap ratio of 7 equity shares of Ipca for every 200 shares of Krebs, with no cash consideration, and will result in a marginal reduction in promoter shareholding from 44.72% to 44.66%. However, Krebs has been incurring continuous losses (total income of only Rs. 26 Crores versus Ipca's Rs. 7431 Crores, mostly from conversion charges) and the amalgamation aims to leverage Ipca's financial strength to turn around the business.

• · Krebs Biochemicals & Industries Ltd. has been continuously incurring losses and is unable to invest in R&D for new fermentation-based APIs.
• · The appointed date for the Scheme is 1st April 2026, effective upon receipt of all approvals.
• · The share exchange ratio is 7 equity shares of Re.1 each of Ipca for every 200 fully paid-up equity shares of Rs.10 each held in Krebs.
• · Equity and preference shares of Krebs held by Ipca shall be cancelled with no consideration issued.
• · Post-scheme promoter shareholding reduces marginally from 44.72% to 44.66% (a drop of only ~0.06 percentage points).
• · Public shareholding increases from 55.28% to 55.34%.
• · Krebs holds a manufacturing facility capable of producing fermentation-based APIs, a capability Ipca currently lacks.
• · Krebs supplies one fermentation-based API used in Ipca's largest-selling formulation, and only a handful of manufacturers exist globally for this API.

26-06-2026

The Board of Krebs Biochemicals & Industries Limited has approved a scheme of amalgamation with Ipca Laboratories Limited, with an appointed date of April 1, 2026. Under the scheme, Krebs (total income ₹26 Cr, loss-making) will be merged into Ipca (total income ₹7,431 Cr) in a share-for-share swap of 7 Ipca shares for every 200 Krebs shares, with no cash consideration. The merger aims to secure supply of a critical fermentation-based API and drug intermediates, while leveraging Ipca's financial strength to revive Krebs' R&D and manufacturing capabilities.

• · Krebs is continuously incurring losses and cannot fund R&D for new fermentation-based APIs.
• · Ipca does not have a fermentation-based API manufacturing capability, which Krebs possesses.
• · Krebs produces one fermentation-based API used in Ipca’s largest selling formulation, with only a handful of global manufacturers.
• · Krebs also produces few drug intermediates used in Ipca’s key APIs.
• · The transaction is a related party transaction and is being done at arm’s length.
• · The board meeting started at 11:30 a.m. and concluded at 1:00 p.m. on June 26, 2026.

26-06-2026

Apollo Pipes Limited (APL) announced a Scheme of Arrangement to amalgamate its wholly-owned step-down subsidiary KML Tradelinks (KTPL) into Kisan Mouldings (KML), and then KML into APL. APL will issue 4.96 equity shares for every 100 shares held in KML. The scheme aims to achieve operational synergies, cost reduction, and a stronger market presence, but comes with significant regulatory approvals and potential dilution for existing APL shareholders.

• · Appointed date for the scheme: April 1, 2026
• · The first step amalgamation (KTPL into KML) involves no issuance of shares as KTPL is a wholly owned subsidiary of KML.
• · The second step amalgamation (KML into APL) share exchange ratio: 4.96 APL shares for every 100 KML shares (face value ₹10 each).
• · Fairness opinion on share exchange ratio provided by Corporate Professionals Capital Private Limited (SEBI registered Category-I Merchant Banker).
• · Registered Valuer for valuation report: Axiology Valuetech Private Limited (IBBI registered).
• · The scheme requires approvals from shareholders, creditors, BSE, NSE, SEBI, and NCLT.
• · KML's promoter holding in APL post-arrangement becomes public holding, leading to promoter dilution from 51.72% to 49.20% in APL.
• · KML shareholders receive APL shares, thus the public shareholding in APL increases from 47.99% to 50.52%.

26-06-2026

NTPC Limited has incorporated a new wholly owned subsidiary, NTPC (Mauritius) Energy Limited, in Mauritius on June 26, 2026, to develop a Floating Solar Photovoltaic (FSPV) project with Battery Energy Storage System (BESS) and pursue other power sector businesses in Mauritius. The subsidiary is capitalized at MUR 1,000,000 (approx. INR 19,80,000) and is a newly incorporated entity with no current turnover. This is a small initial investment for a project development vehicle, with no financial returns expected in the near term.

• · The subsidiary was incorporated pursuant to the disclosure made on 23rd December 2025.
• · The entity is a wholly owned subsidiary of NTPC Limited.
• · No governmental or regulatory approvals have been mentioned as required; the filing lists Ministry of Power, DIPAM, and Registrar of Companies, Mauritius as likely approval bodies.
• · The consideration for acquisition is subscribed in cash.

26-06-2026

Promoter and Director Parmeshwar Ojha sold 5,01,000 equity shares of Gautam Exim Limited on June 24, 2026, reducing his stake from 11.40% to 9.37% of the company. The sale was executed on the BSE via a market transaction, and the disclosure was filed under SEBI Takeover and Insider Trading regulations.

• · The sale was executed on June 24, 2026, and the disclosure was filed on June 26, 2026.
• · The transaction was a market purchase/sale on the BSE.
• · No derivative contracts (futures or options) were held or traded by the promoter.
• · The promoter's remaining shareholding post-sale is 9.37% of the company.

26-06-2026

Crescentis Capital Limited (formerly Som Datt Finance Corporation Ltd.) disclosed an inter-se transfer of 3,00,000 equity shares (1.76% of paid-up capital) within its promoter group via a gift transaction on June 24, 2026. Dr. Bhaskara Rao Bollineni transferred the shares to Mr. Bhavanam Ruthvik Reddy, reducing his holding from 68.80% to 67.04%, while Mr. Reddy's stake increased from 6.17% to 7.94%. The aggregate promoter group shareholding remains unchanged, and the transaction is exempt from open offer requirements under SEBI Takeover Regulations.

• · The transaction was executed off-market by way of gift on June 24, 2026.
• · Disclosures were received from both parties on June 24, 2026, and filed with BSE on June 26, 2026.
• · The company's registered office is at 8-2-502/1/A, Ground Floor, JIVI Towers, Road No 7, Banjara Hills, Hyderabad - 500034.
• · The company was formerly known as Som Datt Finance Corporation Ltd.